Abstract
Objective The aim of this study was to formulate and validate an individualized predictive nomogram for in-hospital incidence of acute respiratory distress syndrome (ARDS) in patients with acute pancreatitis(AP).
Design It was a retrospective cohort study.
Setting Departments of Emergency Medicine of two university-affiliated tertiary hospitals, Changsha, China.
Participants From January 2017 to December 2018, 779 individuals with AP were included in this study.
Primary outcome measures The in-hospital incidence of ARDS was assessed.
Results AP patients were randomly distributed into primary cohort(n=560)and validation cohort(n=219). Based on the primary cohort, risk factors were identified by logistic regression model and a nomogram was performed. Five independent factors including white blood counts(WBC),prothrombin time(PT),albumin(ALB),serum creatinine(SCR) and triglyceride (TG) were associated with in-hospital incidence of ARDS in AP patients. A nomogram was constructed based on the five independent factors with primary cohort of AUC 0.821 and validation cohort of AUC 0.822. Calibration curve analysis indicated that the predicted probability was in accordance with the observed probability in both primary and validation cohorts.
Conclusions The study developed an intuitive nomogram with easily available laboratory parameters for the prediction of in-hospital incidence of ARDS in patients with AP. The incidence of ARDS for an individual patient can be fast and conveniently evaluated by our nomogram.
Strengths and limitations of this study This is the first study to develop a nomogram for predicting the in-hospital incidence of ARDS in AP patients.
For each AP patient, our nomogram enables physicians to directly and conveniently calculate a numeric probability of ARDS.
There might be patient selection biases owing to retrospective nature of our study.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This manuscript was supported by the Sanitation and Health Committee Foundation of Hunan Province, China (20200075).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Datasets used and/or analyzed in the present study were availed by the corresponding author on reasonable request.